You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Long‐Term Safety of Subcutaneous Abatacept in Rheumatoid Arthritis: Integrated Analysis of Clinical Trial Data Representing More Than Four Years of Treatment
|
|---|---|
| Published in |
Arthritis & Rheumatology, July 2014
|
| DOI | 10.1002/art.38687 |
| Pubmed ID | |
| Authors |
Rieke Alten, Jeffrey Kaine, Edward Keystone, Peter Nash, Ingrid Delaet, Mark C Genovese |
| Abstract |
To investigate the safety of long-term subcutaneous (SC) abatacept treatment using integrated clinical trial data obtained in patients with rheumatoid arthritis refractory to traditional disease-modifying antirheumatic drugs. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 25% |
| United States | 1 | 25% |
| United Kingdom | 1 | 25% |
| Unknown | 1 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 2 | 50% |
| Members of the public | 2 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 102 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Spain | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 99 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 16 | 16% |
| Student > Master | 15 | 15% |
| Other | 12 | 12% |
| Researcher | 12 | 12% |
| Student > Postgraduate | 11 | 11% |
| Other | 17 | 17% |
| Unknown | 19 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 49 | 48% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 6% |
| Psychology | 5 | 5% |
| Biochemistry, Genetics and Molecular Biology | 4 | 4% |
| Immunology and Microbiology | 4 | 4% |
| Other | 10 | 10% |
| Unknown | 24 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 September 2014.
All research outputs
#13,175,249
of 22,754,104 outputs
Outputs from Arthritis & Rheumatology
#1,732
of 2,748 outputs
Outputs of similar age
#106,215
of 228,705 outputs
Outputs of similar age from Arthritis & Rheumatology
#46
of 79 outputs
Altmetric has tracked 22,754,104 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,748 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.5. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 228,705 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 79 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.